L. Creevey

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

R. Stallings, A. Davidoff, A. Tivnan, 2012, British Journal of Cancer.

MicroRNA-204 increases sensitivity of neuroblastoma cells to cisplatin and is associated with a favourable clinical outcome

R. Stallings, A. Davidoff, K. Bryan, 2012, British Journal of Cancer.

Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer

A. Hill, P. O'Gaora, L. Young, 2015, Breast Cancer Research.

Altered Steroid Milieu in AI-Resistant Breast Cancer Facilitates AR Mediated Gene-Expression Associated with Poor Response to Therapy

A. Hill, S. Madden, L. Young, 2019, Molecular Cancer Therapeutics.

Modulation of Neuroblastoma Disease Pathogenesis By An Extensive Network of Epigenetically Regulated MicroRNAs

R. Stallings, F. Speleman, J. Vandesompele, 2012, Oncogene.

MicroRNA-497 increases apoptosis in MYCN amplified neuroblastoma cells by targeting the key cell cycle regulator WEE1

R. Stallings, I. Bray, J. Ryan, 2013, Molecular Cancer.

Modulation of chemotherapeutic drug resistance in neuroblastoma SK‐N‐AS cells by the neural apoptosis inhibitory protein and miR‐520f

R. Stallings, P. Buckley, M. Segura, 2015, International journal of cancer.